Skip to main navigation Skip to search Skip to main content

The role of radiotherapy in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline

  • Samuel Ryu
  • , John M. Buatti
  • , Ann Morris
  • , Steven N. Kalkanis
  • , Timothy Charles Ryken
  • , Jeffrey J. Olson
  • University of Iowa
  • Henry Ford Health System
  • Emory University

Research output: Contribution to journalReview articlepeer-review

68 Scopus citations

Abstract

Question: Can re-irradiation (by using conventional radiotherapy, fractionated radiosurgery, or single fraction radiosurgery) be used in patients with progressive glioblastoma multiforme after the first adjuvant combined multimodality treatment with radiation and chemotherapy? Target population: These recommendations apply to adult patients with progressive glioblastoma after first line combined multimodality treatment with chemotherapy and radiation. Recommendations Level III: When the target tumor is amenable for additional radiation, re-irradiation is recommended as it provides improved local tumor control, as measured by best imaging response. Such re-irradiation can take the form of conventional fractionation radiotherapy, fractionated radiosurgery, or single fraction radiosurgery. Level III: Re-irradiation is recommended in order to maintain or improve a patient's neurological status and quality of life prior to any further tumor progression.

Original languageEnglish
Pages (from-to)489-499
Number of pages11
JournalJournal of Neuro-Oncology
Volume118
Issue number3
DOIs
StatePublished - Jul 2014

Keywords

  • Adult
  • Chemotherapy
  • Glioblastoma
  • Progressive
  • Radiation therapy
  • Radiosurgery
  • Recurrent

Fingerprint

Dive into the research topics of 'The role of radiotherapy in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline'. Together they form a unique fingerprint.

Cite this